(Q44123038)

30 November 2017

title

Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus (English)

1 reference

30 November 2017

7

Peter D Siersema

1 reference

30 November 2017

2

Felix W M de Rooij

1 reference

30 November 2017

Petra Hinnen

1

1 reference

30 November 2017

Wim C J Hop

3

1 reference

30 November 2017

Annie Edixhoven

4

1 reference

30 November 2017

Herman van Dekken

5

1 reference

30 November 2017

J H Paul Wilson

6

1 reference

30 November 2017

publication date

1 August 2002

1 reference

Journal of Photochemistry and Photobiology B

30 November 2017

published in

1 reference

30 November 2017

volume

68

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

8-14

1 reference

Biology of gastroesophageal reflux disease: pathophysiology relating to medical and surgical treatment

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Barrett's esophagus: development of dysplasia and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX.

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Mucosal ablation using photodynamic therapy for the treatment of dysplasia: an experimental study in the normal rat stomach

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

The histopathology of treated Barrett's esophagus: squamous reepithelialization after acid suppression and laser and photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Acrylate yellow filters in operating lights protect against photosensitization tissue damage

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Barrett's esophagus, dysplasia, and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Kinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's-like rat esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

Potential efficacy of a delta 5-aminolevulinic acid bioadhesive gel formulation for the photodynamic treatment of lesions of the gastrointestinal tract in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1011-1344%2802%2900324-X

7 January 2021

10.1016/S1011-1344(02)00324-X

Identifiers

DOI

1 reference

30 November 2017

1 reference